Affordable adjunctive: Medlab reveals preliminary probiotic and depression findings, details cancer, NCD plans 22-Feb-2021 By Tingmin Koe Medlab has embarked on clinical trials at varying stages for a number of its probiotics, including those targeted at alleviating depression, mucositis caused by cancer treatment, as well as addressing non-communicable diseases (NCDs).